Terumo Blood and Cell Technologies (Terumo BCT) named Patrick Daly as its chief business officer. This addition comes as the Lakewood company aims to expand its capabilities in response to evolving market segments.
Daly brings over 30 years of experience in the business and health care sectors, having worked both domestically and internationally. He most recently led the MedTech Global Data franchise at IQVIA, a provider of technology solutions in the life sciences industry. Previously, he served as president and CEO of Cohera Medical and continues to serve as an independent board director for BioStem Technologies. His background includes senior leadership roles in strategic marketing, sales and business development at Johnson & Johnson.
“Patrick’s experience acquiring capital and building strategic partnerships complements his experience monetizing data and solutions. This uniquely positions him to integrate our offerings and drive innovation across our business models and go-to-market strategies,” said Antoinette Gawin, president and CEO of Terumo BCT. “His diverse experience will help accelerate our ambitions for double-digit growth.”
“It is a great moment to join Terumo BCT as it continues executing its long-term vision for growth and to meet patients’ unmet needs globally,” said Daly. “I am focused on ensuring our full portfolio, connected with data, software and services, will play a growing role in helping our customers solve healthcare’s toughest challenges, while advancing disease research, therapeutic development and improved access to safe blood worldwide.”
Terumo BCT develops products, software and services that help customers collect and prepare blood and cells to help treat challenging diseases and conditions.
